http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1247010-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0021
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
filingDate 1985-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1988-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7d388c6e010a27b122766b24ba61166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6cb4cbf2f7edb33bd0cb86eebf3eeaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e14e2768436b41e7c6855018eb83ef2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bf9c2718fe9215c4dd7fbfc4e1632f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f80e2fd6e5c573a287a09d521d0149c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a952beea66b35c90edee3cbe8520e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a91413d8ca3550a8a61610a2db81e21e
publicationDate 1988-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1247010-A
titleOfInvention Fibronectin-dextran-drug complex and method of preparation thereof
abstract Abstract of the Disclosure The drug such as antitumor agents or anti-biotics can preferencially be carried to a morbid part, for example, injured tissue and tumor site by admi-nistering its complex with fibronectin combined through an oxidized dextran to repair the morbid part. The complex is prepared by reacting the drug, an oxidized dextran having a cleaved structure of aldohexopyranose ring, and fibronectin.
priorityDate 1984-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID252590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16158474
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09683
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6343
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20287
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63297
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280794
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63298
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11384
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396133
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14268
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ08535
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09910
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32647
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100005469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426334837
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504230
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1MB83
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46874763
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553743
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31299
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6024
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450059958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID740018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105054
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810543
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2335

Total number of triples: 74.